Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $29K 120 sh |
| Oct 23, 2026 traded Oct 22, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $187K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $150K 1,677 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $185K 2,000 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Gheuens SarahChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $56K 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $46K 194 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 6 | Honeycutt JenniferDirector, President and CEO | Option exercise · 10b5-1 plan | M | $204K 7,098 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 6 | Borgeson John A.Chief Financial Officer | Option exercise · 10b5-1 plan | M | $75K 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 5 | Borgeson John A.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $9,491 100 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking | Grant or award · 10b5-1 plan | A | — 252 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | rahim ramiEVP, Pres GM Networking | Grant or award · 10b5-1 plan | A | — 579 sh | Oct 23, 2026 traded Oct 16, 2026 |
| 5 | Lentz DanielCFO & COO | Tax withholding | F | $6,241 1,724 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Option exercise · 10b5-1 plan | M | — 21.9K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 34.4K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $376K 60.0K sh | Oct 23, 2026 traded Oct 23, 2026 |
| 4 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Option exercise · 10b5-1 plan | M | — 15.3K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $463K 2,728 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $267K 1,564 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $379K 60.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 4 | Rogers Daniel MarkDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $227K 19.7K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 3 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | — 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 3 | Borgeson John A.Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 30.0K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 2 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,738 135 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 1 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $154K 900 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 1 | Gheuens SarahChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $19K 500 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 1 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $93K 552 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | $13K 500 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Azar Samak LChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $15K 335 sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6,573 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Option exercise · 10b5-1 plan | M | — 21.4K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Honeycutt JenniferDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 7,098 sh | Oct 23, 2026 traded Oct 23, 2026 |
| 0 | Gheuens SarahChief Medical Officer | Option exercise · 10b5-1 plan | M | $37K 1,489 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 34.4K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6,573 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Bhatt BaijuDirector | Derivative conversion · 10b5-1 plan | C | — 50.9K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Option exercise · 10b5-1 plan | M | $196K 15.3K sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6,573 sh | Oct 23, 2026 traded Oct 21, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Option exercise · 10b5-1 plan | M | $47K 21.9K sh | Oct 23, 2026 traded Oct 22, 2026 |
| 0 | Fox-Geen JeremyChief Financial Officer | Option exercise · 10b5-1 plan | M | — 15.0K sh | Oct 23, 2026 traded Oct 21, 2026 |